Milestone Pharmaceuticals had $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024.
Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback